Abstract PS13-34: Differential efficacy of pegfilgrastim (Peg) in patients (pts) with breast cancer (BC) versus other cancer types for the prevention of docetaxel (Doc) chemotherapy-induced neutropenia (CIN)
Year: 2021
Type: conference-abstract
Source: Cancer Research
Authors: Douglas W. Blayney, Greg Ginn, Lan Huang, Ramon Mohanlal
Institutions: Stanford Cancer Institute, Stanford University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3129746992